Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RIVAROXABAN Cause Extra dose administered? 207 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 207 reports of Extra dose administered have been filed in association with RIVAROXABAN (Rivaroxaban). This represents 0.2% of all adverse event reports for RIVAROXABAN.

207
Reports of Extra dose administered with RIVAROXABAN
0.2%
of all RIVAROXABAN reports
9
Deaths
42
Hospitalizations

How Dangerous Is Extra dose administered From RIVAROXABAN?

Of the 207 reports, 9 (4.3%) resulted in death, 42 (20.3%) required hospitalization, and 3 (1.4%) were considered life-threatening.

Is Extra dose administered Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RIVAROXABAN. However, 207 reports have been filed with the FAERS database.

What Other Side Effects Does RIVAROXABAN Cause?

Gastrointestinal haemorrhage (20,041) Haemorrhage (6,571) Epistaxis (5,629) Rectal haemorrhage (4,501) Off label use (4,463) Haematuria (4,387) Upper gastrointestinal haemorrhage (4,247) Cerebrovascular accident (4,111) Anaemia (3,907) Acute kidney injury (3,735)

What Other Drugs Cause Extra dose administered?

TIRZEPATIDE (6,774) DULAGLUTIDE (3,047) LORATADINE (1,556) DUPILUMAB (1,422) FEXOFENADINE (1,413) NAPROXEN (908) POLYETHYLENE GLYCOL 3350 (589) ACETAMINOPHEN (552) DALFAMPRIDINE (519) FLUTICASONE\SALMETEROL (499)

Which RIVAROXABAN Alternatives Have Lower Extra dose administered Risk?

RIVAROXABAN vs RIVASTIGMINE RIVAROXABAN vs RIVOTRIL RIVAROXABAN vs RIZATRIPTAN RIVAROXABAN vs ROACTEMRA RIVAROXABAN vs ROCURONIUM

Related Pages

RIVAROXABAN Full Profile All Extra dose administered Reports All Drugs Causing Extra dose administered RIVAROXABAN Demographics